title: [Reversal of hepatorenal syndrome with oral misoprostol. Is the dose the key to the response?].
authors.forename: F J
authors.initials: FJ
authors.lastname: Casado Caballero
authors.forename: F J
authors.initials: FJ
authors.lastname: Gallego Rojo
authors.forename: M
authors.initials: M
authors.lastname: González Sánchez
authors.forename: M
authors.initials: M
authors.lastname: Rodríguez Téllez
authors.forename: J
authors.initials: J
authors.lastname: Guilarte López-Mañas
authors.forename: I
authors.initials: I
authors.lastname: Carmona Soria
mesh_terms: D000284:Administration, Oral; D000328:Adult; D003404:Creatinine / Q000097:blood; D004231:Diuresis; D004232:Diuretics / Q000008:administration & dosage*; D005260:Female; D006530:Hepatorenal Syndrome / Q000097:blood / Q000188:drug therapy*; D006801:Humans; D016595:Misoprostol / Q000008:administration & dosage*; D009318:Natriuresis; D013997:Time Factors; D014665:Vasodilator Agents / Q000008:administration & dosage*
chemical_list: D004232:Diuretics; D014665:Vasodilator Agents; D016595:Misoprostol; D003404:Creatinine